Full-Text Search:
Home|Journal Papers|About CNKI|User Service|FAQ|Contact Us|中文
《Contemporary Medicine》 2009-29
Add to Favorite Get Latest Update

Continuous transarterial infusion chemotherapy with Aidi combined with transhepatic arterial embolism in treatment of liver malignant tumor with hepatocellular jaundice

JIN Dong-min,GUO Yu-xiao,HU Hong-tao,LI Hai-liang,GUO Chen-yang,GUO Min 1Department of Oncology,Songxian Traditional Chinese Medicine Hospital,Songxian,Henan province,China,471400 2Department of Radiology,Henan Tumor Hospital,Zhengzhou,Henan Province,China,450003  
Purpose To investigate the effect of continuous transarterial infusion chemotherapy with Aidi combined with transhepatic arterial embolism in treatment of liver malignant tumor.Methods Forty-nine cases with hepatocellular jaundice caused by primary hepatocarcinoma and hepatic metastasis were treated with continuous transarterial infusion chemotherapy with Aidi combined with transhepatic arterial embolism.Results In forty-nine cases,one was dead,two of them gave up during the treatment time,forty-six cases completed treatment.The 0.5-,1-,2-,3-year survival rates were 89.1%,34.8%,17.4%,4.3%.Conclusion For the cases with hepatocellular jaundice caused by primary hepatocarcinoma and hepatic metastasis,continuous transarterial infusion chemotherapy with Aidi combined with transhepatic arterial embolism is an effective way.It can improve the hepatic function,control tumor effectively and enhance immunity and survival rate.
【CateGory Index】: R735.7
Download(CAJ format) Download(PDF format)
CAJViewer7.0 supports all the CNKI file formats; AdobeReader only supports the PDF format.
©2006 Tsinghua Tongfang Knowledge Network Technology Co., Ltd.(Beijing)(TTKN) All rights reserved